During the past decade, Clinical Research Advantage, Inc/Ridge Family Practice conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Advantage, Inc/Ridge Family Practice" #1 sponsor was "Pfizer" with 2 trials, followed by "Biomedical Advanced Research and Development Authority" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "Sucampo Pharma Americas, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Advantage, Inc/Ridge Family Practice" #1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Advantage, Inc/Ridge Family Practice" are "A/Vietnam/H5N1 Influenza Virus" (1 trials), "Acute Migraine" (1 trials), "Influenza" (1 trials), "Meningitis, Meningococcal" (1 trials) and "Opioid-induced Bowel Dysfunction" (1 trials). Many other conditions were trialed in "Clinical Research Advantage, Inc/Ridge Family Practice" in a lesser frequency.

Most popular intervention types in "Clinical Research Advantage, Inc/Ridge Family Practice" are "Biological" (3 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "15 mcg H5N1 (stored as monobulk)" (1 trials), "7.5 mcg H5N1 (stored as monobulk)" (1 trials) and "90 mcg H5N1 (stored as monobulk)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Advantage, Inc/Ridge Family Practice" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Advantage, Inc/Ridge Family Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Clinical Research Advantage, Inc/Ridge Family Practice, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Advantage, Inc/Ridge Family Practice, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".